CD8A and hepatocellular carcinoma: identified pathological responses in patients characterized by intratumoral cellular triads consisting of progenitor CD8+ T cells and CXCL13+ CD4+ T helper cells surrounding mature DCs (referred to as “mregDC”) by analyzing of 20 patients with resectable HCC receiving neoadjuvant cemiplimab.